
Patient-Reported Factors Redefine Alopecia Areata Severity
New research characterizes patient-reported factors beyond scalp hair loss that contribute to alopecia areata severity.
Scalp Lesions: Rare Malignancies Mimic Benign Conditions
Ulcerated scalp lesions, often misdiagnosed as benign, can represent rare malignancies such as sebaceous carcinoma or leukemia cutis.
Down Syndrome: Skin Conditions Demand Dermatologists’ Attention
Individuals with Down syndrome frequently present with specific dermatological conditions that necessitate targeted clinical management and specialist referral.
GLP-1 Receptor Agonists and Psoriatic Disease: A Deep Dive
GLP-1 receptor agonists, primarily for type 2 diabetes and obesity, show emerging evidence for modifying psoriatic disease activity.
Goat Milk Formula Linked With Less Atopic Dermatitis
Infants fed goat milk formula demonstrated a reduced incidence of atopic dermatitis compared to those on cow milk formula, according to recent observations.
Paroxetine's Mechanism in Rosacea: Serotonin Pathway Clues
Paroxetine, a selective serotonin reuptake inhibitor, may modulate neurovascular dysregulation in rosacea via serotonin pathway interactions.
Remibrutinib Resolves Chronic Inducible Urticaria Symptoms
A novel BTK inhibitor, remibrutinib, demonstrated efficacy in resolving symptoms of chronic inducible urticaria in clinical trials.
FDA Approves Skinvive for Facial Wrinkles, Including 'Tech Neck' Lines
The FDA has approved Skinvive, an injectable hyaluronic acid gel, for improving skin smoothness and reducing facial wrinkles, including those on the neck.
FDA Approves First New Sunscreen Active Ingredient in Two Decades
The FDA has approved a new sunscreen active ingredient, bemotrizinol, marking the first such approval in over 20 years. This offers a new option for broad-spectrum UV protection.